2020
DOI: 10.1016/j.surg.2019.09.022
|View full text |Cite
|
Sign up to set email alerts
|

Effect of surgical delay on survival outcomes in patients undergoing curative resection for primary hepatocellular carcinoma: Inverse probability of treatment weighting using propensity scores and propensity score adjustment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(30 citation statements)
references
References 24 publications
0
28
0
Order By: Relevance
“…While most previous studies have performed PSM based on pre‐operative parameters of qualitative hepatic function (Indocyanine Green testing, albumin, bilirubin, prothrombin time, platelets and so on), the present study has focused on clinicopathological factors of increasing significance in today's context. With better patient selection and pre‐operative optimisation, most patients with physiologically significant derangements in hepatic synthetic and excretory function are now excluded from MH 15–19,21 . With the advent of MILR, factors such as cirrhosis, tumour size, multifocality, previous liver resections and concomitant abdominal operations (non‐cholecystectomy) are now of greater concern to attending surgeons, all of which are addressed in this study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While most previous studies have performed PSM based on pre‐operative parameters of qualitative hepatic function (Indocyanine Green testing, albumin, bilirubin, prothrombin time, platelets and so on), the present study has focused on clinicopathological factors of increasing significance in today's context. With better patient selection and pre‐operative optimisation, most patients with physiologically significant derangements in hepatic synthetic and excretory function are now excluded from MH 15–19,21 . With the advent of MILR, factors such as cirrhosis, tumour size, multifocality, previous liver resections and concomitant abdominal operations (non‐cholecystectomy) are now of greater concern to attending surgeons, all of which are addressed in this study.…”
Section: Discussionmentioning
confidence: 99%
“…The selection criteria, pre‐operative workup and surgical technique applied in our institution for both MILR and OLR have been reported previously 11,12,18–22 . MILR was first performed in SGH in 2006 and has since been systematically advocated by several senior surgeons since 2012.…”
Section: Methodsmentioning
confidence: 99%
“…A cohort study of 12102 patients with HCC conducted by Croome et al showed that patients with TTS more than 60 days after hepatectomy had a lower risk of death and a higher 5-year survival rate [14] , The authors speculate that patients with severe disease and a higher risk of late death may undergo early surgery, while patients with lower invasiveness will receive surgery later. And receive a more comprehensive preoperative evaluation.The Tousif Kabir et al study was the most similar to this study regarding the design [17] , in which they used time cut-off points of 30, 60, and 90 days in the analysis, and compared OS between each group and reported no signi cant differences. We also only reviewed the relationship between the different TTS and OS according to the different time cut-off points, but the selection of the time cut-off point was different.…”
Section: Discussionmentioning
confidence: 95%
“…The pathological results showed that 9.5% of the patients had cirrhosis, 27.6% had microvascular invasion, 12.1% had venous thromboembolism, and 88.4% were highly differentiated. Severe complications occurred in 2.6% of the patients, with a median hospital stay of 18 (14)(15)(16)(17)(18)(19)(20)(21)(22) days. The median OS of patients was 37 (23.4-57.6) months (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…These facts cannot be overseen, also, cancer is a bigger problem than COVID-19 from patient's perspective. Table 1 summarises various studies addressing the impact of time to treatment initiation or delaying surgeries on cancer survival [14][15][16][17][18][19][20][21][22][23][24][25][26][27]. Keeping these concerns in mind, some guidelines have recommended a possible triage ( Table 2) to offer surgeries, even during the course of an active pandemic, for certain precarious malignancies who are known to have rapid progression.…”
Section: Cancer Surgery In Covid-19 Outbreakmentioning
confidence: 99%